The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients treated for monomorphic B-cell post-transplant lymphoproliferative disorder: A single-center experience.
 
Imran Nizamuddin
No Relationships to Disclose
 
Jia Qi Xiong
No Relationships to Disclose
 
Marcus Watkins
No Relationships to Disclose
 
David Russler-Germain
Consulting or Advisory Role - AstraZeneca; Cartography Biosciences; Regeneron
Research Funding - Genentech (Inst)
 
Dilan Patel
No Relationships to Disclose
 
Todd Fehniger
Stock and Other Ownership Interests - Indapta Therapeutics; Orca Bio; WUGEN, Inc.
Consulting or Advisory Role - Affimed Therapeutics; AI proteins; Smart Immune; WUGEN, Inc.
Research Funding - Affimed Therapeutics (Inst); AI proteins (Inst); HCW Biologics (Inst); WUGEN, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patents filed by my institution where i am listed as a co-inventor, licensed to Wugen, Inc. (Inst)
 
Armin Ghobadi
Consulting or Advisory Role - Amgen; Atara Biotherapeutics; Bristol-Myers Squibb/Roche; CARGO Therapeutics; Celgene; CovACE Nanotechnology; crispr therapeutics; EUSA Pharma; Kite/Gilead; Novartis; WUGEN, Inc.
Research Funding - Amgen; Genentech; Kite, a Gilead company; Secura Bio
 
Amanda Cashen
Consulting or Advisory Role - ADC Therapeutics; Secura Bio
Research Funding - Secura Bio (Inst)
 
Brad Kahl
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Merck; Pfizer; Roche; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Genentech (Inst)
 
Nancy Bartlett
Consulting or Advisory Role - Foresight Diagnostics; Genmab/AbbVie; Kite, a Gilead company; Pfizer/SeaGen; Roche/Genentech
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb/Celgene (Inst); Forty Seven (Inst); Genmab/Abbvie (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Millennium (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Neha Mehta-Shah
Consulting or Advisory Role - Acrotech Biopharma; AstraZeneca; Autolus; Daiichi Sankyo/UCB Japan; Genentech/Roche; Janssen Oncology; Kyowa Hakko Kirin; Ono Pharmaceutical (Inst); Secura Bio
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); C4 Therapeutics (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo; Dizal Pharma (Inst); Genentech/Roche (Inst); Innate Pharma (Inst); Morphosys (Inst); Seagen (Inst); Secura Bio (Inst); Treeline Biosciences (Inst); Verastem (Inst); Yingli Pharma (Inst)